APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Industry Growth and Trends Forecast to 2032

6 March 202685 pages

Choose your research edition.

Industry ResearchCardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

According to APO Research, the global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution market include Deepwise, Lepu Medical, NeuMiva, G K Healthcare, Sense Time, United Imaging, Infervision, Shukun and FOSUN AITROX, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market by Company

Deepwise

Lepu Medical

NeuMiva

G K Healthcare

Sense Time

United Imaging

Infervision

Shukun

FOSUN AITROX

Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Segment by Type

Public Cloud

Private Cloud

Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Segment by Application

Hospital

Clinic

Imaging Center

Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Region (2021-2026) Table 4. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Region (2027-2032) Table 6. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Share by Type (2021-2026) Table 9. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Share Forecasted by Type (2027-2032) Table 11. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Share by Application (2021-2026) Table 24. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Share Forecasted by Application (2027-2032) Table 26. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Industry Trends Table 37. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Industry Drivers Table 38. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Industry Opportunities and Challenges Table 39. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Industry Restraints Table 40. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue Market Share by Company (2021-2026) Table 42. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Key Company Headquarters & Area Served Table 44. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Company, Product Type & Application Table 45. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Deepwise Company Information Table 49. Deepwise Business Overview Table 50. Deepwise Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Deepwise Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product Portfolio Table 52. Deepwise Recent Development Table 53. Lepu Medical Company Information Table 54. Lepu Medical Business Overview Table 55. Lepu Medical Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Lepu Medical Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product Portfolio Table 57. Lepu Medical Recent Development Table 58. NeuMiva Company Information Table 59. NeuMiva Business Overview Table 60. NeuMiva Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. NeuMiva Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product Portfolio Table 62. NeuMiva Recent Development Table 63. G K Healthcare Company Information Table 64. G K Healthcare Business Overview Table 65. G K Healthcare Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. G K Healthcare Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product Portfolio Table 67. G K Healthcare Recent Development Table 68. Sense Time Company Information Table 69. Sense Time Business Overview Table 70. Sense Time Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Sense Time Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product Portfolio Table 72. Sense Time Recent Development Table 73. United Imaging Company Information Table 74. United Imaging Business Overview Table 75. United Imaging Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. United Imaging Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product Portfolio Table 77. United Imaging Recent Development Table 78. Infervision Company Information Table 79. Infervision Business Overview Table 80. Infervision Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Infervision Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product Portfolio Table 82. Infervision Recent Development Table 83. Shukun Company Information Table 84. Shukun Business Overview Table 85. Shukun Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Shukun Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product Portfolio Table 87. Shukun Recent Development Table 88. FOSUN AITROX Company Information Table 89. FOSUN AITROX Business Overview Table 90. FOSUN AITROX Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. FOSUN AITROX Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product Portfolio Table 92. FOSUN AITROX Recent Development Table 93. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2021-2026) & (US$ Million) Table 95. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Country (2021-2026) Table 96. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share Forecast by Country (2027-2032) Table 98. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2021-2026) & (US$ Million) Table 100. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Country (2021-2026) Table 101. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share Forecast by Country (2027-2032) Table 103. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2021-2026) & (US$ Million) Table 105. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Country (2021-2026) Table 106. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share Forecast by Country (2027-2032) Table 108. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2021-2026) & (US$ Million) Table 110. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Country (2021-2026) Table 111. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share Forecast by Country (2027-2032) Table 113. Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2021-2026) & (US$ Million) Table 115. Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Country (2021-2026) Table 116. Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share Forecast by Country (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product Image Figure 3. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size (2021-2032) & (US$ Million) Figure 5. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Region: 2025 VS 2032 Figure 6. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Region (2021-2032) Figure 7. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Public Cloud Image Figure 13. Global Public Cloud Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Private Cloud Image Figure 15. Global Private Cloud Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Type 2025 VS 2032 Figure 18. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Share by Type (2021-2032) Figure 19. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Share by Type (2021-2032) Figure 21. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Share by Type (2021-2032) Figure 23. Hospital Image Figure 24. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Clinic Image Figure 26. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Imaging Center Image Figure 28. Global Imaging Center Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Application 2025 VS 2032 Figure 31. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Share by Application (2021-2032) Figure 32. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Share by Application (2021-2032) Figure 34. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Country (2021-2032) Figure 41. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Country (2021-2032) Figure 44. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Country (2021-2032) Figure 47. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Country (2021-2032) Figure 50. Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Public Cloud
  • Private Cloud
Applications
  • Hospital
  • Clinic
  • Imaging Center
Companies covered
  • Deepwise
  • Lepu Medical
  • NeuMiva
  • G K Healthcare
  • Sense Time
  • United Imaging
  • Infervision
  • Shukun
  • FOSUN AITROX

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Region (2021-2032)
  5. 1.4.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Region (2021-2026)
  6. 1.4.2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Region (2027-2032)
  7. 1.5 Key Regions Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size (2021-2032)
  8. 1.5.1 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (2021-2032)
2 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Public Cloud
  3. 2.1.2 Private Cloud
  4. 2.2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Type
  5. 2.2.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Regions
  9. 2.3.1 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Type (2021-2026)
3 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Imaging Center
  5. 3.2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Application
  6. 3.2.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Regions
  10. 3.3.1 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Industry Trends
  2. 4.2 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Industry Drivers
  3. 4.3 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Industry Opportunities and Challenges
  4. 4.4 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue (2021-2026)
  2. 5.2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Key Company Headquarters & Area Served
  4. 5.4 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Company, Product Type & Application
  5. 5.5 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Deepwise
  2. 6.1.1 Deepwise Company Information
  3. 6.1.2 Deepwise Business Overview
  4. 6.1.3 Deepwise Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Deepwise Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product Portfolio
  6. 6.1.5 Deepwise Recent Developments
  7. 6.2 Lepu Medical
  8. 6.2.1 Lepu Medical Company Information
  9. 6.2.2 Lepu Medical Business Overview
  10. 6.2.3 Lepu Medical Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Lepu Medical Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product Portfolio
  12. 6.2.5 Lepu Medical Recent Developments
  13. 6.3 NeuMiva
  14. 6.3.1 NeuMiva Company Information
  15. 6.3.2 NeuMiva Business Overview
  16. 6.3.3 NeuMiva Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 NeuMiva Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product Portfolio
  18. 6.3.5 NeuMiva Recent Developments
  19. 6.4 G K Healthcare
  20. 6.4.1 G K Healthcare Company Information
  21. 6.4.2 G K Healthcare Business Overview
  22. 6.4.3 G K Healthcare Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 G K Healthcare Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product Portfolio
  24. 6.4.5 G K Healthcare Recent Developments
  25. 6.5 Sense Time
  26. 6.5.1 Sense Time Company Information
  27. 6.5.2 Sense Time Business Overview
  28. 6.5.3 Sense Time Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Sense Time Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product Portfolio
  30. 6.5.5 Sense Time Recent Developments
  31. 6.6 United Imaging
  32. 6.6.1 United Imaging Company Information
  33. 6.6.2 United Imaging Business Overview
  34. 6.6.3 United Imaging Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 United Imaging Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product Portfolio
  36. 6.6.5 United Imaging Recent Developments
  37. 6.7 Infervision
  38. 6.7.1 Infervision Company Information
  39. 6.7.2 Infervision Business Overview
  40. 6.7.3 Infervision Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Infervision Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product Portfolio
  42. 6.7.5 Infervision Recent Developments
  43. 6.8 Shukun
  44. 6.8.1 Shukun Company Information
  45. 6.8.2 Shukun Business Overview
  46. 6.8.3 Shukun Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Shukun Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product Portfolio
  48. 6.8.5 Shukun Recent Developments
  49. 6.9 FOSUN AITROX
  50. 6.9.1 FOSUN AITROX Company Information
  51. 6.9.2 FOSUN AITROX Business Overview
  52. 6.9.3 FOSUN AITROX Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 FOSUN AITROX Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Product Portfolio
  54. 6.9.5 FOSUN AITROX Recent Developments
7 North America
  1. 7.1 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2021-2026)
  3. 7.3 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2021-2026)
  3. 8.3 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2021-2026)
  3. 10.3 South America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Solution Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst